(Q34743687)

4 August 2017

title

Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice (English)

1 reference

4 August 2017

6

Josef Pfeilschifter

1 reference

4 August 2017

author name string

Waltraud Pfeilschifter

1

1 reference

4 August 2017

Bożena Czech-Zechmeister

2

1 reference

4 August 2017

Marian Sujak

3

1 reference

4 August 2017

Christian Foerch

4

1 reference

4 August 2017

Thomas A Wichelhaus

5

1 reference

4 August 2017

publication date

9 March 2011

1 reference

Experimental & translational stroke medicine

4 August 2017

published in

1 reference

4 August 2017

volume

3

1 reference

4 August 2017

page(s)

2

1 reference

Creative Commons Attribution 2.0 Generic

4 August 2017

copyright license

start time

9 March 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Fingolimod provides long-term protection in rodent models of cerebral ischemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

Oral pharmacokinetic and pharmacodynamic effects of FTY720 in cats

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

Bench to bedside: the quest for quality in experimental stroke research

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

1,026 experimental treatments in acute stroke

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

Central nervous system injury-induced immune deficiency syndrome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

FTY720: early clinical experience.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F2040-7378-3-2

Hematoma size as major modulator of the cellular immune system after experimental intracerebral hemorrhage.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F2040-7378-3-2

FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine produ

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068098

Medical Complications After Stroke

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21388542

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21388542

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/2040-7378-3-2

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference